Educational background in Pharmaceutical Sciences. More than 15 years of combined academic and industrial experience in pharmaceutical and biotechnology field. Experience of leading teams in a matrix structure and representing those cross functionally. Expertise in developing formulations for various modalities such as nucleic acid-based drugs, small molecules, and cyclic peptides. Expertise in formulation development of lipid and polymer-based nanoparticles, amorphous solid dosage form development, and controlled release formulation development using polymer nano- and microparticles and depot forming lipid formulations. Expertise in developing platforms such as High Throughput and Automation, novel dosage form presentation such as dry powder, and mucosal vaccination routes for mRNA-LNPs.